About Us
- Our Philosophy
- The Industry and Us
Our Strategy
Our Team
Media / Science Center
Contact Us
Investors

Press Releases

Investors

Overview
News
Events & Presentations
- Events
- Presentations
Financial Info
Stock Data
Filings & Financials
Governance
Investor Resources

News
Press Releases
Email Alerts
In The News
Videos

Year

Category

Jan 05, 2009 8:00am EST

Ensysce Biosciences Inc. Appoints Dr. D. Lynn Kirkpatrick as President and CEO

Previous Page
Page 1
…
Page 9
Page 10
Page 11
Page 12
Page 13
Page 14
Page 15
Page 16
Page 17
Page 18

rss_feed News RSS

Email Alerts
Company Profile
Contacts
RSS News Feed

Biotech company committed to stemming the prescription drug abuse epidemic.

Our proprietary prodrug technologies are designed to improve the care of patients with chronic pain while reducing the human and economic costs associated with prescription drug abuse.

About Us

Our philosophy
The Industry and Us

Our strategy

Our Technology
Key Applications
Clinical Programs
Preclinical Programs
Pipeline
Our Partnerships

Our Team

Executive Management
Board of Directors
Clinical Advisory Board

Contact Us

Investors

Follow Ensysce on social media:

/company/Ensyscebio
@Ensyscebio
/Ensyscebio